Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.47%
SPX
+0.40%
IXIC
+0.24%
FTSE
-0.20%
N225
-0.88%
AXJO
-0.49%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

180 Life Sciences: Key Developments and Insights in Biotechnology Sector

about 5 hours ago
publisher logo
Cashu

180 Life Sciences: Key Updates and Insights on Recent Developments

1 day ago
publisher logo
Cashu

Please provide the content you'd like me to summarize, and I'll be happy to help!

3 days ago

Key Stats

Market Cap
12.13M
Dividend Yield
0.00%
P/E Ratio
-0.70
EPS
-15.77
Revenue
-
Avg. Volume
783.51K

About

What does ATNF do?
180 Life Sciences is a clinical-stage biotechnology company based in Palo Alto, California, focused on developing novel drugs for inflammatory diseases using three platforms, primarily targeting anti-TNF therapies. The company went public on June 7, 2017, and currently employs four full-time staff.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Stocks
Health Care
atnf
180 Life Sciences
ATNF
+0.81 (+38.26%)
2.945
USD
At close at Jul 25, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials